期刊文献+

直接经皮冠状动脉介入治疗应用抽吸导管的临床疗效观察 被引量:4

Efficacy of transcatheter aspiration of coronary thrombus in primary percutaneous coronary intervention for AMI
下载PDF
导出
摘要 目的观察血栓抽吸导管在急性心肌梗死(AMI)患者中行直接PCI的疗效。方法选择我院因AMI住院行直接PCI,并于术中应用了血栓抽吸导管的患者共202例(抽吸组),另选择因AMI住院并行PCI的患者249例(对照组),比较两组即刻及近期临床疗效。结果抽吸组在发病距血管再通时间[(5.3±2.8)h vs (6.0±3.1)h,P=0.012]、直接支架置入率(44.1% vs 30.5%,P=0.003)和术后达TIMI 3级血流(90.1% vs 81.1%,P=0.008)的情况明显好于对照组,而无复流/慢血流发生率则明显减少(3.5% vs 8.4%,P=0.032)。术后抽吸组在肌钙蛋白I峰值[(44.7±31.2)μg/L vs (52.5±34.8)μg/L,P=0.012]及肌酸激酶同工酶峰值[(152.0±73.6)u/L vs (166.0±70.5)U/L,P=0.041]、即刻心电图的ST段回落率(67.8% vs 57.0%,P=0.002)、住院期间心力衰竭发生率(11.4% vs 22.9%,P=0.002)、再次心肌梗死发生率(1.0% vs 4.4%,P=0.044)、病死率(3.5% vs8.8%,P=0.032)等方面与对照组比较差异有统计学意义。结论 AMI患者行直接PCI过程中应用血栓抽吸导管可明显减少无复流/慢血流等并发症的发生,从而降低病死率,改善近期预后。 Objective To evaluate the efficacy of transcatheter aspiration of coronary thrombus during primary percutaneous coronary intervention(PCI) in patients with acute myocardial infarction(AMI). Methods The patients with AMI undergoing primary PCI and receiving transcatherer aspiration thrombectomy( n = 202) were enrolled in study group,and those who had AMI hut only received routine PCI( n = 249)were enrolled in control group. The immediate and short-term outcomes between the two groups were observed. Results In the study group, both rate of direct implantation of stent and TIMI flow grade 3 obtained were superior to the control group,and significant difference in rate of no-reflow/slow flow was observed between the two groups. There were lower peak serum levels of cTnⅠ [(44.7±31.2) μg/L vs (52.5±34. 8) μg/L, P =0. 012] and CK-MB[(152. 0±73. 6) U/L vs (166.0±70. 5) U/L, P =0.041],and higher ST segment resolution rate(67.8% vs 57.0%, P =0. 002) in the study group. The heart failure rate(11. 4% vs 22.9%, P =0.002) ,re-infarction rate(1.0% vs 4.4%, P =0. 044) and fatality(3.5% vs 8.8%, P = 0. 032) in hospital were decreased in the study group compared with control group. Conclusion Transcatheter thrombus aspiration in patients with AMI was effective. It could decrease noreflow/slow flow and achieved good immediate and short-term clinical prognosis.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2009年第6期404-406,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 心肌梗塞 血栓形成 血管成形术 经腔 经皮冠状动脉 抽吸 预后 myocardial infarction thrombosis angioplasty, transluminal, percutaneous suction prognosis
  • 相关文献

参考文献5

  • 1Burzotta F,Trani C,Romagnoli E,et al.A pilot study with a new,rapid-exchange,thrombus-aspirating device in patients with thrombus-containing lesion,the Diver C.E.study.Catheter Cardiovasc Interv,2006,67:887-893.
  • 2Svilaas T,Vander Horst IC,Zijlstra F,et al.Thrombus aspiration during percutaneous coronary intervention in Acute Myocardial Infarction Study(TAPAS) study design.Am Heart J,2006,151:e1-e7.
  • 3Silva-Orrego P,Colombo P,Bigi R,et al.Thromhus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction,the DEAR-MI (Dethromhosis to Enhance Acute Reperfusion in Myocardial Infarction) study.J Am Coll Cardiol,2006,48:1552-1559.
  • 4Niccoli G,Lanza GA,Shaw S,et al.Endothelin-1 and acute myocardial infarction:a no-reflow mediator after successful percutaneous myocardial revascularization.Eur Heart J,2006,27:1793-1798.
  • 5柯福升,宋克义,郑志英,向南坡,刘子龙,路秀敏.血栓抽吸导管在急性心肌梗死患者治疗中的临床应用[J].中华老年心脑血管病杂志,2008,10(2):106-108. 被引量:14

二级参考文献11

  • 1王乐丰,张大鹏.急性心肌梗死急诊再灌注治疗后心肌组织无复流的防治[J].临床内科杂志,2007,24(1):11-13. 被引量:5
  • 2Resnic FS,Wainstein M,Lee MK,et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J, 2003,145 : 42- 46.
  • 3Hisashi U, Toshiaki K, Mitsunori I, et al. The distal protection during primary percutaneous coronary intervention alleviates the adverse effects of large thrombus burden on myocardial reperfusion. Circulation,2006,70:232-238.
  • 4Svilaas T,van der Horst IC, Zijlstra F, et al. Thrombus aspiration during percutaneous coronary intervention in Acute Myocardial Infarction Study (TAPAS) study design. Am Heart J ,2006,151 :5971-5977.
  • 5Reffelmann T, Kloner RA. The no-reflow phenomenon:a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol,2006,101:359-372.
  • 6Iwakura K,Ito H,Ikushima M,et al. Association between hy perglycemia and the no-fellow phenomenon in patients with a cute myocardial infarction. J Am Coll Cardiol, 2003,41: 127-132.
  • 7Grube E,Schofer J,Webb J,et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol, 2002,89 : 941-945.
  • 8Kloner RA, Dai Wangde. Glycoprotein Ⅱ b/ Ⅲ a inhibitors and no reflow. J Am Coll Cardiol,2004,43:284-286.
  • 9Baim DS,Wahr D,George B,et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 2002,105 : 1285-1290.
  • 10Limbruno U, Micheli A, De Carlo M, et al. Mechanical prevention of distal embolization during primary angioplasty: safety,feasibility,and impact on myocardial reperfusion. Circulation, 2003,108:171-176.

共引文献13

同被引文献19

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部